Cargando…
к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
Opioids are effective analgesics for the management of moderate to severe cancer pain. Here we show that κ opioid receptor (KOR) agonists act as anti-angiogenic factors in tumors. Treatment with KOR agonists, U50,488H and TRK820, significantly inhibited human umbilical vein endothelial cell (HUVEC)...
Autores principales: | Yamamizu, Kohei, Furuta, Sadayoshi, Hamada, Yusuke, Yamashita, Akira, Kuzumaki, Naoko, Narita, Michiko, Doi, Kento, Katayama, Shiori, Nagase, Hiroshi, Yamashita, Jun K., Narita, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827603/ https://www.ncbi.nlm.nih.gov/pubmed/24225480 http://dx.doi.org/10.1038/srep03213 |
Ejemplares similares
-
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells
por: Kuzumaki, N, et al.
Publicado: (2012) -
Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2012) -
Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2013) -
Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice
por: Tanaka, Kenichi, et al.
Publicado: (2023) -
PS13. Role of the hypothalamic µ-opioidergic systems in the anti-tumor immune response
por: Hamada, Yusuke, et al.
Publicado: (2016)